The association of serum total bile acid with new-onset hypertension during pregnancy

Table 2 Patients in different degree of TBA level

TBA	No	PE			EOPE			LOPE			Mild PE			Severe PE
		No. (%)	*p value*^a	OR (95% CI)	No. (%)	*p value*^a	OR (95% CI)^a	No. (%)	*p value*^a	OR (95% CI)^a	No. (%)	*p value*^b	OR (95% CI)	No. (%)	*p value*^b	OR (95% CI)
< 1.6	865	270 (31.25)		1(reference)	112(12.95)		1(reference)	158(18.27)		1(reference)	147 (54.44)		1(reference)	123 (45.56)		1(reference)
1.6 to < 4.1	1322	545 (41.26)	< 0.001	1.82(1.47–2.26)	241(18.23)	0.001	1.62(1.23–2.12)	304(23.0)	0.002	1.45(1.15–1.82)	237 (43.49)	0.002	0.61(0.45–0.83)	308 (56.51)	0.002	1.64(1.2–2.24)
4.1 to < 8.2	361	192 (53.33)	< 0.001	2.37(1.71–3.28)	93(25.76)	0.001	1.93(1.33–2.81)	99(27.42)	0.004	1.63(1.17–2.28)	74 (38.54)	0.005	0.56(0.38–0.84)	118 (61.46)	0.005	1.78(1.19–2.66)
8.2 to < 10	37	23 (63.89)	0.001	4.63(1.89–11.35)	10(27.03)	0.011	3.46(1.32–9.04)	13(35.14)	0.003	3.75(1.57–8.98)	5 (21.74)	0.007	0.23(0.08–0.67)	18 (78.26)	0.007	4.27(1.48–12.3)

Adjustment for AST, ALT, T bilirubin, TC, TG, ALB, pregestational diabetes, nulliparity and IVF
PE preeclampsia, EOPE early-onset PE, LOPE late-onset PE
^aCompared PE patients with non-PE patients in total pregnant women
^bCompared mild PE or severe PE with all PE patients

ISSN: 1471-2393